A detailed history of Cullen/Frost Bankers, Inc. transactions in Danaher Corp stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 132,255 shares of DHR stock, worth $31.1 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
132,255
Previous 134,819 1.9%
Holding current value
$31.1 Million
Previous $33.7 Million 9.15%
% of portfolio
0.51%
Previous 0.49%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$239.25 - $280.76 $613,437 - $719,868
-2,564 Reduced 1.9%
132,255 $36.8 Million
Q2 2024

Aug 05, 2024

SELL
$235.51 - $267.98 $2.56 Million - $2.92 Million
-10,890 Reduced 7.47%
134,819 $33.7 Million
Q1 2024

May 10, 2024

SELL
$224.58 - $256.19 $1.42 Million - $1.62 Million
-6,309 Reduced 4.15%
145,709 $36.4 Million
Q4 2023

Feb 06, 2024

SELL
$185.1 - $233.13 $389,080 - $490,039
-2,102 Reduced 1.36%
152,018 $35.2 Million
Q3 2023

Nov 02, 2023

SELL
$233.08 - $265.59 $1.37 Million - $1.56 Million
-5,876 Reduced 3.67%
154,120 $38.2 Million
Q2 2023

Aug 04, 2023

SELL
$224.99 - $256.14 $1.03 Million - $1.17 Million
-4,564 Reduced 2.77%
159,996 $38.4 Million
Q1 2023

May 05, 2023

SELL
$239.75 - $277.0 $855,188 - $988,059
-3,567 Reduced 2.12%
164,560 $41.5 Million
Q4 2022

Feb 13, 2023

BUY
$241.42 - $282.29 $1.58 Million - $1.85 Million
6,558 Added 4.06%
168,127 $44.6 Million
Q3 2022

Nov 07, 2022

SELL
$247.06 - $1507.4 $47,435 - $289,420
-192 Reduced 0.12%
161,569 $41.7 Million
Q2 2022

Aug 05, 2022

SELL
$237.11 - $299.66 $1.41 Million - $1.78 Million
-5,952 Reduced 3.55%
161,761 $41 Million
Q1 2022

May 09, 2022

BUY
$257.27 - $315.76 $609,472 - $748,035
2,369 Added 1.43%
167,713 $49.2 Million
Q4 2021

Feb 07, 2022

SELL
$292.08 - $329.01 $3.37 Million - $3.79 Million
-11,525 Reduced 6.52%
165,344 $54.4 Million
Q3 2021

Nov 04, 2021

SELL
$272.21 - $332.43 $1.78 Million - $2.17 Million
-6,533 Reduced 3.56%
176,869 $53.9 Million
Q2 2021

Aug 05, 2021

SELL
$225.08 - $271.69 $1.29 Million - $1.56 Million
-5,750 Reduced 3.04%
183,402 $49.2 Million
Q1 2021

May 05, 2021

SELL
$212.38 - $245.9 $2.37 Million - $2.74 Million
-11,157 Reduced 5.57%
189,152 $42.6 Million
Q4 2020

Feb 08, 2021

SELL
$212.5 - $245.46 $4.01 Million - $4.63 Million
-18,875 Reduced 8.61%
200,309 $44.5 Million
Q3 2020

Nov 05, 2020

SELL
$177.16 - $215.33 $753,638 - $916,013
-4,254 Reduced 1.9%
219,184 $47.2 Million
Q2 2020

Aug 05, 2020

BUY
$128.7 - $176.83 $2.77 Million - $3.81 Million
21,558 Added 10.68%
223,438 $39.5 Million
Q1 2020

May 01, 2020

BUY
$121.39 - $169.05 $593,232 - $826,147
4,887 Added 2.48%
201,880 $27.9 Million
Q4 2019

Feb 06, 2020

SELL
$133.47 - $153.48 $301,241 - $346,404
-2,257 Reduced 1.13%
196,993 $30.2 Million
Q3 2019

Nov 01, 2019

SELL
$135.4 - $146.47 $154,762 - $167,415
-1,143 Reduced 0.57%
199,250 $28.8 Million
Q2 2019

Aug 01, 2019

SELL
$124.88 - $143.73 $346,542 - $398,850
-2,775 Reduced 1.37%
200,393 $28.6 Million
Q1 2019

Apr 30, 2019

BUY
$97.62 - $132.29 $2.33 Million - $3.15 Million
23,824 Added 13.28%
203,168 $26.8 Million
Q4 2018

Feb 06, 2019

SELL
$94.85 - $109.54 $1.72 Million - $1.98 Million
-18,090 Reduced 9.16%
179,344 $18.5 Million
Q3 2018

Oct 29, 2018

SELL
$98.13 - $108.9 $399,290 - $443,114
-4,069 Reduced 2.02%
197,434 $21.5 Million
Q2 2018

Jul 27, 2018

SELL
$96.1 - $103.24 $2.16 Million - $2.32 Million
-22,505 Reduced 10.05%
201,503 $19.9 Million
Q1 2018

May 11, 2018

BUY
$92.16 - $103.8 $5.47 Million - $6.16 Million
59,317 Added 36.02%
224,008 $21.9 Million
Q4 2017

Jan 31, 2018

BUY
$85.26 - $94.62 $1.08 Million - $1.2 Million
12,715 Added 8.37%
164,691 $15.3 Million
Q3 2017

Nov 02, 2017

BUY
$79.29 - $88.45 $12.1 Million - $13.4 Million
151,976
151,976 $13 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Cullen/Frost Bankers, Inc. Portfolio

Follow Cullen/Frost Bankers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.